Aldosterone: Sodium Retention, Potassium Excretion & Blood Pressure Regulation
Aldosterone a hormone which regulates sodium balance, potassium balance, and extracellular fluid volume. By controlling how much sodium the kidneys retain and how much potassium they excrete, aldosterone directly influences blood volume, venous return, cardiac output, and arterial blood pressure. While antidiuretic hormone (ADH) determines how much water the body retains relative to solute, aldosterone determines how much solute-driven volume the body retains. These systems form the core of long-term blood pressure and electrolyte regulation.
What You Need to Know
Aldosterone is a mineralocorticoid hormone produced by the zona glomerulosa of the adrenal cortex and is one of the body’s most powerful regulators of blood volume, blood pressure, and potassium balance. It acts primarily on the late distal convoluted tubule and collecting ducts of the nephron, where it alters the expression and activity of key ion transport proteins. By increasing sodium reabsorption and potassium secretion, aldosterone directly links electrolyte handling to circulatory control.
Aldosterone release is tightly regulated by two major physiological signals:
the renin–angiotensin–aldosterone system (RAAS), which responds to low blood pressure or reduced renal perfusion
plasma potassium concentration, which rises when potassium accumulates in the blood
These inputs ensure that aldosterone responds appropriately to both volume status and electrolyte needs.
Once released, aldosterone stimulates epithelial sodium channels and sodium–potassium ATPase pumps in principal cells of the distal nephron. This increases sodium movement from the tubular fluid into the bloodstream while driving potassium into the urine. Because water follows sodium osmotically, sodium retention leads to expansion of extracellular fluid volume and a rise in arterial pressure. Through these coordinated effects, aldosterone allows the kidneys to defend circulation while preventing dangerous elevations in plasma potassium.
Beyond the Basics
Stimuli for Aldosterone Secretion
The predominant stimulus for aldosterone release is angiotensin II, which provides an indication of how well the kidneys are being perfused. When blood pressure falls, renal blood flow decreases, or sodium delivery to the macula densa drops, the juxtaglomerular apparatus releases renin. This activates the renin–angiotensin system and leads to the formation of angiotensin II, which directly stimulates aldosterone secretion from the adrenal cortex. In this way, aldosterone becomes a key hormonal link between kidney blood flow and long-term blood pressure regulation.
Plasma potassium concentration provides a second, independent control pathway. Even a small rise in extracellular potassium strongly stimulates aldosterone secretion. This allows the body to defend against hyperkalaemia even when blood pressure is normal. In effect, aldosterone constantly balances two priorities: preserving circulation through sodium retention and protecting cardiac electrical stability through potassium excretion.
Adrenocorticotropic hormone (ACTH) from the pituitary can transiently increase aldosterone release, but it does not provide meaningful long-term regulation. Its role is permissive rather than regulatory, ensuring the adrenal cortex remains responsive to angiotensin II and potassium signals.
Cellular Mechanism of Aldosterone Action
Because aldosterone is a steroid hormone, it does not act through surface receptors. Instead, it diffuses across the cell membrane of principal cells in the distal nephron and binds to intracellular mineralocorticoid receptors. The hormone–receptor complex then enters the nucleus and alters gene transcription, increasing the production and activity of key transport proteins.
These changes include increased expression of epithelial sodium channels on the apical membrane, enhanced sodium–potassium ATPase pumps on the basolateral membrane, and increased potassium channel activity. Together, these adaptations allow sodium to move efficiently from the tubular fluid into the bloodstream while potassium is driven in the opposite direction into the urine. Water follows the retained sodium by osmosis, producing volume expansion without directly altering water permeability. Because this is a genomic effect, aldosterone acts more slowly than ADH, but its impact is sustained and powerful.
Aldosterone & Sodium-Driven Volume Control
Aldosterone controls total body sodium content rather than simply redistributing water. Since sodium is the dominant extracellular osmole, the amount of sodium in the body determines how much water is retained in the extracellular space. When aldosterone levels rise, sodium retention increases, extracellular volume expands, venous return to the heart rises, and arterial blood pressure increases. When aldosterone levels fall, sodium is lost in the urine, extracellular volume contracts, and blood pressure falls. This is why aldosterone is central to long-term blood pressure regulation, while neural reflexes and vascular tone control short-term fluctuations.
Aldosterone & Potassium Homeostasis
Potassium regulation is tightly linked to aldosterone because potassium secretion occurs primarily in the same nephron segments where aldosterone acts. When plasma potassium rises, aldosterone secretion increases, stimulating potassium secretion and preventing dangerous accumulation in the blood. When potassium levels fall, aldosterone secretion decreases, conserving potassium.
This coupling explains several clinical patterns. Aldosterone excess leads to hypokalaemia, while aldosterone deficiency causes hyperkalaemia. Drugs that block aldosterone or its receptor therefore commonly raise plasma potassium. Because potassium concentration strongly affects cardiac membrane potential, aldosterone plays a crucial indirect role in cardiac rhythm stability.
Interaction with Acid–Base Balance
Aldosterone also influences acid–base regulation by stimulating hydrogen ion secretion in intercalated cells of the collecting ducts. As hydrogen ions are excreted, new bicarbonate is generated and returned to the bloodstream. This means aldosterone promotes alkalinisation of the blood when it is elevated. As a result, aldosterone excess tends to produce metabolic alkalosis, while aldosterone deficiency predisposes to metabolic acidosis. This linkage explains why disorders of sodium and potassium handling are often accompanied by characteristic acid–base abnormalities in renal and adrenal disease.
Clinical Connections
Disorders of aldosterone secretion produce highly characteristic clinical syndromes because aldosterone sits at the intersection of sodium balance, potassium homeostasis, and acid–base regulation. In primary hyperaldosteronism, excessive aldosterone release causes sustained sodium retention and potassium loss. This leads to:
resistant hypertension from chronic volume expansion
hypokalaemia causing muscle weakness, cramps, and arrhythmias
metabolic alkalosis due to increased hydrogen ion secretion
suppressed renin levels because the kidneys sense volume overload
These patients often present with difficult-to-control blood pressure and unexplained low potassium.
In hypoaldosteronism, aldosterone deficiency prevents the kidneys from retaining sodium or excreting potassium. The resulting sodium wasting leads to volume depletion and hypotension, while potassium retention causes hyperkalaemia and increases the risk of cardiac arrhythmias. At the same time, reduced hydrogen ion secretion produces metabolic acidosis. This pattern is commonly seen in adrenal insufficiency and in hyporeninaemic hypoaldosteronism associated with diabetic kidney disease.
Many cardiovascular and renal medications directly modify aldosterone physiology. ACE inhibitors and angiotensin receptor blockers (ARBs) reduce aldosterone secretion by interrupting angiotensin II signalling, lowering blood pressure and limiting sodium retention. Potassium-sparing diuretics either block aldosterone receptors or epithelial sodium channels in the collecting duct, preventing potassium loss but increasing the risk of hyperkalaemia, especially when kidney function is impaired.
In heart failure, chronic activation of aldosterone contributes not only to sodium and water retention but also to myocardial fibrosis, vascular inflammation, and progressive ventricular dysfunction. This explains why aldosterone antagonists such as spironolactone and eplerenone improve survival in advanced heart failure, even beyond their effects on blood pressure and fluid balance.
Concept Check
Why does aldosterone primarily regulate extracellular fluid volume rather than plasma osmolality?
Why does high plasma potassium stimulate aldosterone independently of blood pressure?
How does aldosterone increase sodium reabsorption at the cellular level?
Why does aldosterone excess cause hypokalaemia and metabolic alkalosis?
Why are aldosterone antagonists dangerous in patients with advanced renal failure?